| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |